[1]
“Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature”, Nepal J Dermatol Venereol & Leprol, vol. 20, no. 2, pp. 3–15, Sep. 2022, doi: 10.3126/njdvl.v20i2.45638.